An experimental Alzheimer’s drug outperforms one just approved by the FDA
(By Jon Hamilton for NPR) Patients in the early stages of Alzheimer’s may soon have a new option to stave
Read More(By Jon Hamilton for NPR) Patients in the early stages of Alzheimer’s may soon have a new option to stave
Read MoreThe FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read More(By Rylee Wilson for Becker’s Hospital Review) Leqembi, the newly-approved drug that can slow the progression of Alzhemier’s disease, will
Read More(Source – www.cms.gov/newsroom) Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (the brand name for lecanemab) following
Read More(By Arthur Allen for KFF Health News) This week the FDA is expected to approve what many scientists and doctors
Read More(By Jon Hamilton for NPR) The first drug shown to slow down Alzheimer’s disease is likely to receive full approval
Read More(Source – www.cms.gov) The Centers for Medicare & Medicaid Services (CMS) is committed to fostering innovation while ensuring that people
Read More(By Arthur Allen for KFF Health News) On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant
Read More(By Yuki Noguchi for NPR) Toni Dezomits is used to facing death. She served in the Gulf War and later
Read More(By Helen Branswell for STAT) The Food and Drug Administration approved a second vaccine to protect older adults against RSV
Read More